EmulTech is a high tech company that helps pharmaceutical organizations with more efficient drug delivery, in order to contribute to a better quality of life. We specialize in microsphere development using microencapsulation in microfluidics. For this, EmulTech develops the INFINITY product line, which helps researchers and product developers creating controlled microencapsulated drug samples for research and for production.
Fully automated development tool
Uniform microspheres 1 μm and up
Typical production volumes 1 - 100 gram dry powder / hour
INFINITY is a versatile platform suitable for various different applications.
to discuss your application.
EmulTech's unique technology ensures easy scale up of your application while maintaining the quality of the particle characteristics.
INFINITY is designed with cGMP-production in mind. The closed system with disposable wetted components is easily turned into an aseptic process.
Microfluidic emulsification, is a much-reported method to make uniform and controlled soft matter structures, like emulsions, microcapsules, and microspheres.
Your flow calculator
The flow calculator ensures shortened development time. It allows you to make better informed development decisions.
After preclinical development the flow calculator ensures high reproducibility between batches and straightforward scale up to clinical and market relevant volumes.
"We are really pleased with the quality of the particles made by EmulTech."
Sr. VP Formulation Development, US
Reproducible microparticle formation
EmulTech makes reproducible microparticle formation easy. The company is dedicated to the translation of micro particle concepts into production processes. EmulTech offers services and equipment for early laboratory development as well as scaled equipment for clinical development and full scale manufacturing.
"The formulation was extremely complex. It was good to see how well it behaved in EmulTech's systems!"
Head of Complex formulations, EU based Pharma company.
EmulTech and Avivia Enter Collaboration
Published on January 30, 2017
Developing new strategies for cancer drug delivery, in Denmark and at Duke
Published on January 12, 2017
Watch our new instruction video of the INFINITY Mini
Published on 11 december, 2016
Watch EmulTech's new instruction video of the INFINITY Mini
2nd Annual Complex Formulations Symposium 2016
Published on 17 oktober, 2016
Read more about EmulTech's third annual symposium at the TU/e this year.
EmulTech's new cooperation(Dutch)
Published on July 5, 2016
Read about EmulTech's new cooperation with Catharina Ziekenhuis Eindhoven and Fontys TNW!
EmulTech featured by Bioencapsulation Research Group
Published on February 10, 2016
Microfluidic encapsulation is used for the development of Sustained Release Microspheres.
EmulTech featured in OnDrugDelivery
Published on January 15, 2016
Ophthalmic drug delivery is a growing field of interest in the drug delivery industry. EmulTech's unique capabilities offer great advantages in the development of ophthalmics!
EmulTech's Youtube Channel
Published on October 12, 2015
For your convenience, EmulTech collected and uploaded its movies and animations to the EmulTech Youtube Channel.
Poster presentation ECIS
Published on September 24, 2015
Scale up from single micro droplets to microfluidic scale up production is successful after characterization of single particles to determine the optimal process window.
HOW TO EXTEND YOUR PATENT LIFE
Published on June 24, 2015
EmulTech offers pharmaceutical companies a unique opportunity in life cycle management of originator drug products by providing a platform for Next Generation Drug Product development
Take process uncertainty out of the equation
Published on June 11, 2015
EmulTech's INFINITY platform provides unique process understanding allowing for high reproducibility in development and during scale up.
Meet EmulTech at Achema
Published on May 30, 2015
Meet with EmulTech at the Achema event in Frankfurt am Main, Germany.
INFINITY user base keeps growing
Published on May 15, 2015
Another undisclosed global ophthalmics company has adopted the INFINITY platform for its drug delivery development program.
Robin de Bruijn, Founder and CEO
Marion Timmermans, Managing Director
Tom Derks, Product Manager
Linda Nouwens, Management Assistant
Linda van de Ven, Marketing & Communications Advisor
Olivier van Duuren, Marketing & Communications Support